Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 Apr 18;162(8):1157–1163.

Rheumatology: 2. What laboratory tests are needed?

K Shojania 1
PMCID: PMC1232370  PMID: 10789634

Full Text

The Full Text of this article is available as a PDF (217.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron M., Zendel I. HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. J Rheumatol. 1989 May;16(5):631–636. [PubMed] [Google Scholar]
  2. Esdaile J. M., Abrahamowicz M., Joseph L., MacKenzie T., Li Y., Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum. 1996 Mar;39(3):370–378. doi: 10.1002/art.1780390304. [DOI] [PubMed] [Google Scholar]
  3. González-Gay M. A., Rodríguez-Valverde V., Blanco R., Fernández-Sueiro J. L., Armona J., Figueroa M., Martínez-Taboada V. M. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. Arch Intern Med. 1997 Feb 10;157(3):317–320. doi: 10.1001/archinte.1997.00440240081012. [DOI] [PubMed] [Google Scholar]
  4. Hagen E. C., Daha M. R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Lüdemann J., Rasmussen N., Sinico R. A. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998 Mar;53(3):743–753. doi: 10.1046/j.1523-1755.1998.00807.x. [DOI] [PubMed] [Google Scholar]
  5. Hall A. P., Barry P. E., Dawber T. R., McNamara P. M. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med. 1967 Jan;42(1):27–37. doi: 10.1016/0002-9343(67)90004-6. [DOI] [PubMed] [Google Scholar]
  6. Hawkins B. R., Dawkins R. L., Christiansen F. T., Zilko P. J. Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum. 1981 May;24(5):743–746. doi: 10.1002/art.1780240524. [DOI] [PubMed] [Google Scholar]
  7. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum. 1991 Aug;34(8):1065–1068. doi: 10.1002/art.1780340819. [DOI] [PubMed] [Google Scholar]
  8. Lichtenstein M. J., Pincus T. Rheumatoid arthritis identified in population based cross sectional studies: low prevalence of rheumatoid factor. J Rheumatol. 1991 Jul;18(7):989–993. [PubMed] [Google Scholar]
  9. Liszewski M. K., Kahl L. E., Atkinson J. P. The functional role of complement genes in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol. 1989 Oct;1(3):347–352. doi: 10.1097/00002281-198901030-00018. [DOI] [PubMed] [Google Scholar]
  10. Lockshin M. D., Bonfa E., Elkon K., Druzin M. L. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum. 1988 Jun;31(6):697–701. doi: 10.1002/art.1780310601. [DOI] [PubMed] [Google Scholar]
  11. Love L. A., Leff R. L., Fraser D. D., Targoff I. N., Dalakas M., Plotz P. H., Miller F. W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991 Nov;70(6):360–374. doi: 10.1097/00005792-199111000-00002. [DOI] [PubMed] [Google Scholar]
  12. Myklebust G., Gran J. T. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996 Nov;35(11):1161–1168. doi: 10.1093/rheumatology/35.11.1161. [DOI] [PubMed] [Google Scholar]
  13. Niles J. L. Value of tests for antineutrophil cytoplasmic autoantibodies in the diagnosis and treatment of vasculitis. Curr Opin Rheumatol. 1993 Jan;5(1):18–24. doi: 10.1097/00002281-199305010-00004. [DOI] [PubMed] [Google Scholar]
  14. Pittman J. R., Bross M. H. Diagnosis and management of gout. Am Fam Physician. 1999 Apr 1;59(7):1799-806, 1810. [PubMed] [Google Scholar]
  15. Shmerling R. H., Delbanco T. L. The rheumatoid factor: an analysis of clinical utility. Am J Med. 1991 Nov;91(5):528–534. doi: 10.1016/0002-9343(91)90190-9. [DOI] [PubMed] [Google Scholar]
  16. Shmerling R. H., Delbanco T. L., Tosteson A. N., Trentham D. E. Synovial fluid tests. What should be ordered? JAMA. 1990 Aug 22;264(8):1009–1014. [PubMed] [Google Scholar]
  17. Sox H. C., Jr, Liang M. H. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med. 1986 Apr;104(4):515–523. doi: 10.7326/0003-4819-104-4-515. [DOI] [PubMed] [Google Scholar]
  18. Tan E. M., Feltkamp T. E., Smolen J. S., Butcher B., Dawkins R., Fritzler M. J., Gordon T., Hardin J. A., Kalden J. R., Lahita R. G. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997 Sep;40(9):1601–1611. doi: 10.1002/art.1780400909. [DOI] [PubMed] [Google Scholar]
  19. Walz LeBlanc B. A., Gladman D. D., Urowitz M. B. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. J Rheumatol. 1994 Dec;21(12):2239–2241. [PubMed] [Google Scholar]
  20. ter Borg E. J., Horst G., Hummel E. J., Limburg P. C., Kallenberg C. G. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990 May;33(5):634–643. doi: 10.1002/art.1780330505. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES